{
     "PMID": "23454012",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20131126",
     "LR": "20160119",
     "IS": "1879-0720 (Electronic) 0928-0987 (Linking)",
     "VI": "49",
     "IP": "2",
     "DP": "2013 May 13",
     "TI": "Memantine-sulfur containing antioxidant conjugates as potential prodrugs to improve the treatment of Alzheimer's disease.",
     "PG": "187-98",
     "LID": "10.1016/j.ejps.2013.02.013 [doi] S0928-0987(13)00072-9 [pii]",
     "AB": "The approved treatments for Alzheimer's disease (AD) exploit mainly a symptomatic approach based on the use of cholinesterase inhibitors or N-methyl-D-aspartate (NMDA) receptor antagonists. Natural antioxidant compounds, able to pass through the blood-brain barrier (BBB), have been extensively studied as useful neuroprotective agents. A novel approach towards excitotoxicity protection and oxidative stress associated with excess beta amyloid (Abeta) preservation in AD is represented by selective glutamatergic antagonists that possess as well antioxidant capabilities. In the present work, GSH (1) or (R)-alpha-lipoic acid (LA) (2) have been covalently linked with the NMDA receptor antagonists memantine (MEM). The new conjugates, proposed as potential antialzheimer drugs, should act both as glutamate receptor antagonists and radical scavenging agents. The physico-chemical properties and \"in vitro\" membrane permeability, the enzymatic and chemical stability, the demonstrated \"in vitro\" antioxidant activity associated to the capacity to inhibit Abeta(1-42) aggregation makes at least compound 2 a promising candidate for treatment of AD patients.",
     "CI": [
          "Copyright (c) 2013 Elsevier B.V. All rights reserved."
     ],
     "FAU": [
          "Sozio, Piera",
          "Cerasa, Laura S",
          "Laserra, Sara",
          "Cacciatore, Ivana",
          "Cornacchia, Catia",
          "Di Filippo, Ester S",
          "Fulle, Stefania",
          "Fontana, Antonella",
          "Di Crescenzo, Antonello",
          "Grilli, Massimo",
          "Marchi, Mario",
          "Di Stefano, Antonio"
     ],
     "AU": [
          "Sozio P",
          "Cerasa LS",
          "Laserra S",
          "Cacciatore I",
          "Cornacchia C",
          "Di Filippo ES",
          "Fulle S",
          "Fontana A",
          "Di Crescenzo A",
          "Grilli M",
          "Marchi M",
          "Di Stefano A"
     ],
     "AD": "Dipartimento di Farmacia, Universita G. D'Annunzio, Via dei Vestini 31, 66100 Chieti, Italy.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20130227",
     "PL": "Netherlands",
     "TA": "Eur J Pharm Sci",
     "JT": "European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences",
     "JID": "9317982",
     "RN": [
          "0 (Amyloid beta-Peptides)",
          "0 (Antioxidants)",
          "0 (Excitatory Amino Acid Antagonists)",
          "0 (Membranes, Artificial)",
          "0 (Neuroprotective Agents)",
          "0 (Peptide Fragments)",
          "0 (Prodrugs)",
          "0 (Reactive Oxygen Species)",
          "0 (Receptors, N-Methyl-D-Aspartate)",
          "0 (amyloid beta-protein (1-42))",
          "0 (lipoyl-memantine)",
          "73Y7P0K73Y (Thioctic Acid)",
          "GAN16C9B8O (Glutathione)",
          "W8O17SJF3T (Memantine)",
          "X4W3ENH1CV (Norepinephrine)"
     ],
     "SB": "IM",
     "MH": [
          "Alzheimer Disease/drug therapy",
          "Amyloid beta-Peptides/chemistry",
          "Animals",
          "Antioxidants/*chemistry/pharmacology",
          "Cell Line",
          "Excitatory Amino Acid Antagonists/*chemistry/pharmacology",
          "Glutathione/*chemistry/pharmacology",
          "Hippocampus/cytology",
          "Humans",
          "Male",
          "Memantine/*analogs & derivatives/*chemistry/pharmacology",
          "Membranes, Artificial",
          "Neuroprotective Agents/chemistry/pharmacology",
          "Norepinephrine/metabolism",
          "Peptide Fragments/chemistry",
          "Prodrugs/*chemistry/pharmacology",
          "Rats",
          "Rats, Sprague-Dawley",
          "Reactive Oxygen Species/metabolism",
          "Receptors, N-Methyl-D-Aspartate/agonists/antagonists & inhibitors",
          "Synaptosomes/drug effects/metabolism",
          "Thioctic Acid/*analogs & derivatives/*chemistry/pharmacology"
     ],
     "EDAT": "2013/03/05 06:00",
     "MHDA": "2013/12/16 06:00",
     "CRDT": [
          "2013/03/05 06:00"
     ],
     "PHST": [
          "2012/09/18 00:00 [received]",
          "2013/02/04 00:00 [revised]",
          "2013/02/05 00:00 [accepted]",
          "2013/03/05 06:00 [entrez]",
          "2013/03/05 06:00 [pubmed]",
          "2013/12/16 06:00 [medline]"
     ],
     "AID": [
          "S0928-0987(13)00072-9 [pii]",
          "10.1016/j.ejps.2013.02.013 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Eur J Pharm Sci. 2013 May 13;49(2):187-98. doi: 10.1016/j.ejps.2013.02.013. Epub 2013 Feb 27.",
     "term": "hippocampus"
}